Creative Planning
CRNX icon

Creative Planning’s Crinetics Pharmaceuticals CRNX Stock Holding History

Creative Planning’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.95M Buy
53,637
+6,316
+13% +$282K ﹤0.01% 1903
2025
Q4 		$2.2M Buy
47,321
+6,749
+17% +$300K ﹤0.01% 1651
2025
Q3 		$1.69M Buy
40,572
+12,103
+43% +$387K ﹤0.01% 1671
2025
Q2 		$819K Sell
28,469
-1,445
-5% -$44.6K ﹤0.01% 2026
2025
Q1 		$1M Buy
29,914
+3,078
+11% +$115K ﹤0.01% 1712
2024
Q4 		$1.37M Buy
26,836
+7,028
+35% +$393K ﹤0.01% 1404
2024
Q3 		$1.01M Buy
19,808
+6,811
+52% +$351K ﹤0.01% 1500
2024
Q2 		$582K Buy
12,997
+2,224
+21% +$103K ﹤0.01% 1827
2024
Q1 		$504K Buy
+10,773
New +$422K ﹤0.01% 1842

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return